Founded
Address
BioRelix Inc
5 Science Park
401 Winchester Avenue
New Haven, CT 06511
United States
Phone
Website
KANDO id: 452786
Corporate information
Official name
BioRelix Inc
Registration country
Official identities
US CIK 0001373982
Company type
Advanced fight against drug resistant microbes by attacking novel targets with novel drugs.Funding rounds
N/A USD 269,000
USD 269,000 ( )
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Connecticut Innovations Inc (CI) | USD 269,000 (USD 269,000) Led the round. |
N/A USD 2,560,000
USD 2,560,000 ( )
Investor | Profile | Country | Notes | |
---|---|---|---|---|
OpGen Inc | Provider of Whole Genome Mapping technologies for high-precision microbial analysis markets. | |||
Brian Dixon | Individual investor. | |||
New Leaf Venture Partners (NLV) | Follow-on investment. | |||
Novartis Venture Funds | The corporate venturing arm of Novartis. | Follow-on investment. |
Series A USD 25,750,000
USD 25,750,000 ( )
Investor | Profile | Country | Notes | |
---|---|---|---|---|
CHL Medical Partners (Ronald W Lennox) | Venture capital firm focused on early-stage healthcare sectors. | Follow-on investment. Led the round. | ||
Aisling Capital | Initial investment. | |||
New Leaf Venture Partners (NLV) | Initial investment. | |||
Alexandria Real Estate Equities Inc | Follow-on investment. | |||
Elm Street Ventures | Follow-on investment. | |||
Novartis Venture Funds | The corporate venturing arm of Novartis. | Follow-on investment. |
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Alexandria Real Estate Equities Inc | Initial investment. | |||
CHL Medical Partners | Venture capital firm focused on early-stage healthcare sectors. | Initial investment. | ||
Elm Street Ventures | Initial investment. | |||
Novartis Venture Funds | The corporate venturing arm of Novartis. | Initial investment. |
Investment activity status
Active investor